Search Results Search Sort by RelevanceMost Recent Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373.